CD20 role in pathophysiology of Hodgkin’s disease
Summary Hodgkin’s lymphoma (HL) is a tumor comprising non-malignant and malignant B-cells. Classical HL expresses CD15+ and CD30+ antigens, and 20 to 40% of patients are CD20+. This antigen is a ligand free protein present in B lymphocyte cells and its function is not well known. Some studies sugges...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Médica Brasileira
|
Series: | Revista da Associação Médica Brasileira |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000900810&lng=en&tlng=en |